Global Apheresis Market size was US$ 3,029.2 million in 2022 and is estimated to reach a valuation of US$ 6,551.3 million by 2031, growing at a CAGR of 8.7% during the forecast period from 2023 to 2031.
The exponential rise in the global apheresis market is due to the prevalence of hematological disorders like sickle cell anemia and blood cancers is likely to rise, as is the demand for source plasma by different biopharmaceutical companies. Additionally, there will be an increase in the introduction and approval of apheresis systems throughout the forecast period from 2023 to 2031.
Get a Free Sample Report Here- https://www.astuteanalytica.com/request-sample/apheresis-market
The increased incidence of hematological illnesses emerges as the key reason pushing the apheresis market, ranking among the market’s notable drivers. For instance, anemia is a significant global public health issue that affects both young children and pregnant women, according to the information provided by the World Health Organization in 2023. According to current studies and estimates from the WHO, 40% of pregnant women and roughly 42% of children under the age of five are anemic worldwide.
The global market is expanding due to the rising demand for plasmapheresis. There is a growing need for plasmapheresis as a therapy option for autoimmune and neurological conditions like multiple sclerosis and myasthenia gravis. The aging population, which the UN projects will number 1.5 billion by 2050, and rising healthcare expenses, which the World Bank forecasts hit $8.7 trillion in 2020, are expected to cause the need for blood products like plasma and platelets to rise even more.
Blood Collection Center Control More Than Half of the Revenue Share
The blood collection centers accounted for about 68.1% of revenue share in the market. The prevalence of chronic diseases, the rising cost of healthcare, and the rising need for blood products all contribute to this market dominance. For instance, according to the WHO, chronic illnesses, including cancer, diabetes, cardiovascular disease, and respiratory conditions would account for 86% of the 90 million yearly fatalities by 2050, a shocking increase of 90% in absolute numbers from 2019.
The sustained growth of the market is due to government initiatives to promote blood donation, rising degrees of automation in blood collection facilities, and raising public awareness of the importance of blood donation. For instance, the WHO requests that governments, partners, and stakeholders in Africa make investments in bolstering and maintaining blood programs on World Blood Donor Day in 2023. Through the fractionation of local plasma, the WHO Regional Office for Africa is collaborating with partners to make the most of the knowledge and resources present in the area to guarantee greater access to the supply of plasma-derived goods.
North America Controlled 31% of Market Revenue Share
In 2022, North America had the highest market share of 31.5%. The increased incidence of malignancies and chronic illnesses in the area is the cause of this dominance. Additionally, the expansion of the apheresis market in the North American area will be due to the rise in the number of complicated surgical procedures and the rising demand for blood components.
According to data supplied by the American Cancer Society for the year 2022, there were roughly 60,650 new cases of leukemia in the country. In the United States, there were reportedly 472,714 persons living with leukemia in 2019, according to the National Cancer Institute 2022. The statistics provided above clearly indicate that the number of leukemia cases is increasing every year.
For the full report, please follow this link:- https://www.astuteanalytica.com/industry-report/apheresis-market
Reduced white blood cell count Apheresis is typically used to treat leukemia patients with abnormally high blood white cell counts. As a result, there will be a rise in the market demand for apheresis due to the rising incidence of leukemia in the United States.
According to the American Association for the Surgery of Trauma, there are over 3 million non-fatal injuries and over 150,000 fatal injuries caused by injury each year in the United States. In order to treat or manage the damage, some type of surgical surgery is used. As a result, the rising number of injuries will increase the need for surgical treatments, drive up the demand for blood component transfusions, and ultimately drive up the market demand for apheresis.
Top 5 Players Contributed to 55% of Revenue Share to the Market
In 2022, the top five businesses had around 55% of the revenue share, showing that there is now fierce competition among both global and local competitors. B. Braun SE, Asahi Kasei Kuraray Medical Co., Ltd., Charles River Laboratories, Fresenius SE & Co. KGAA, Terumo Corporation, and others are some of the major companies competing in the worldwide apheresis market.
Recent advancements in automation, data analysis, and integration with electronic health record (EHR) systems have emerged as prominent trends changing the industry as a result of the enormous R&D expenditures made by these organizations.
List of Key Companies
- Asahi Kasei Medical Co. Ltd.
- B. Braun Melsungen AG
- Baxter International Inc.
- Cerus Corporation
- Charles River Laboratories International, Inc.
- Haemonetics Corporation
- Kaneka Corporation
- Kawasumi Laboratories Inc
- Nikkiso Co., Ltd.
- Terumo BCT, Inc
- Fresenius Kabi
- Other Prominent Players
The global apheresis market segmentation focuses on Product, Type, Procedure, Technology, End User, and Region.
- Apheresis Disposables
- Apheresis Devices
- Automated blood collection (Donor Apheresis)
- Therapeutic Apheresis
- Membrane Separation
- Selective Adsorption
By End User
- Blood Collection Center
- North America
- The U.S.
- Western Europe
- The UK
- Rest of Western Europe
- Eastern Europe
- Rest of Eastern Europe
- Western Europe
- Asia Pacific
- Australia & New Zealand
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- Saudi Arabia
- South Africa
- Rest of MEA
- South America
- Rest of South America
The request of this Sample Report Here- https://www.astuteanalytica.com/request-sample/apheresis-market
About Astute Analytica
Astute Analytica is a global analytics and advisory company that has built a solid reputation in a short period, thanks to the tangible outcomes we have delivered to our clients. We pride ourselves in generating unparalleled, in-depth and uncannily accurate estimates and projections for our very demanding clients spread across different verticals. We have a long list of satisfied and repeat clients from a wide spectrum including technology, healthcare, chemicals, semiconductors, FMCG, and many more. These happy customers come to us from all across the Globe. They are able to make well-calibrated decisions and leverage highly lucrative opportunities while surmounting the fierce challenges all because we analyze for them the complex business environment, segment-wise existing and emerging possibilities, technology formations, growth estimates, and even the strategic choices available. In short, a complete package. All this is possible because we have a highly qualified, competent, and experienced team of professionals comprising of business analysts, economists, consultants, and technology experts. In our list of priorities, you-our patron come at the top. You can be sure of best cost-effective, value-added package from us, should you decide to engage with us.
BSI Business Park, H-15,Sector-63, Noida- 201301- India
Phone: +1-888 429 6757 (US Toll Free); +91-0120- 4483891 (Rest of the World)